Druggable targets and immunological mechanisms for type 1 diabetes treatment: Genetic evidence from multi‐omics Mendelian randomization combined with meta‐analysis

Documenti analoghi

• Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysis
  di: Kang Li, et al.
  Pubblicazione: (2025)
• Investigating the correlation of hip circumference to cardiovascular disease and type‐2 diabetes using Mendelian randomization
  di: Hongtao Liu, et al.
  Pubblicazione: (2024)
• Causal association between cystatin C and diabetic retinopathy: A two‐sample Mendelian randomization study
  di: Yimeng Ruan, et al.
  Pubblicazione: (2024)
• Integrative multi‐omics suggests core gene dysregulation of histidine metabolism in diabetic kidney disease
  di: Jiang Tan, et al.
  Pubblicazione: (2026)
• Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large‐scale bidirectional Mendelian randomization and external validation study
  di: Keyu Guo, et al.
  Pubblicazione: (2024)